Though increasing understanding and remarkable clinical successes have been made,
enormous challenges remain to be solved in the field of cancer immunotherapy. In this …

Herein, we integrate the Hepa1–6 liver cancer-specific neoantigen, toll-like receptor 9
agonist and stimulator of interferon genes agonist by silk-hydrogel package, and combine …

Cancer immunotherapy has revolutionized cancer treatment by leveraging the immune
system to target and eliminate tumor cells. Implantable biomaterials, such as hydrogels …

Immunotherapy has become a powerful clinical strategy to improve the survival benefit and
quality of life for patients with advanced-stage cancer. Yet the therapeutic efficacy of cancer …

In recent years an array of three-dimensional (3D) in vitro tumor constructs has been
developed to mimic the actual tumor pathophysiology. The advances in this field have their …

The half-time of cells and molecules used in immunotherapy is limited. Scaffolds-based
immunotherapy against cancer may increase the half-life of the molecules and also support …

El melanoma cutáneo es un tipo de cáncer de piel cuya incidencia ha aumentado
significativamente incluso a una tasa más alta que otros tipos de cáncer. Uno de los …

Cancer is a life-threatening disorder, and is the second-leading cause of death worldwide,
with an estimated 606,520 deaths projected in the USA alone for 2020 [1]. Traditional …